Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 180 | 1,146 | 1,352 | 1,723 | 1,978 |
| Marketable Securities | N/A | N/A | N/A | 667 | 1,675 |
| Receivables | 838 | 899 | 477 | 847 | 1,324 |
| Inventories | 627 | 868 | 1,007 | 777 | 1,058 |
| Other current assets | 70 | 21 | 75 | 324 | 321 |
| TOTAL | $1,715 | $2,934 | $2,911 | $4,338 | $6,355 |
| Non-Current Assets | |||||
| PPE Net | 645 | 1,070 | 1,609 | 2,297 | 2,984 |
| Intangibles | 0 | 0 | 0 | 94 | 94 |
| Other Non-Current Assets | 1,310 | 1,252 | 1,277 | 1,240 | 1,191 |
| TOTAL | $1,955 | $2,322 | $2,885 | $3,632 | $4,269 |
| Total Assets | $3,670 | $5,256 | $5,797 | $7,969 | $10,624 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 651 | 167 | 333 |
| Accounts payable and accrued liabilities | 946 | 950 | 673 | 1,052 | 584 |
| Accrued Expenses | 225 | 164 | 162 | 308 | 1,170 |
| Other current liabilities | N/A | 33 | 23 | 528 | 782 |
| TOTAL | $1,828 | $2,238 | $3,205 | $3,918 | $4,965 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 167 |
| Deferred Revenues | 176 | 276 | 490 | 316 | 1,167 |
| Other Non-Current Liabilities | 325 | 348 | 310 | 1,540 | 358 |
| TOTAL | $1,461 | $1,571 | $1,658 | $1,642 | $577 |
| Total Liabilities | $3,289 | $3,808 | $4,864 | $5,560 | $5,542 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,495 | 17,779 | 16,729 | 15,595 | 14,805 |
| Common Shares | 114,763 | 114,355 | 113,963 | 113,019 | 111,653 |
| Retained earnings | -123,762 | -122,189 | -121,057 | -117,804 | -113,372 |
| Other shareholders' equity | 9,380 | 9,282 | 8,027 | 7,195 | 6,801 |
| TOTAL | $381 | $1,448 | $933 | $2,409 | $5,082 |
| Total Liabilities And Equity | $3,670 | $5,256 | $5,797 | $7,969 | $10,624 |